Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism
Clinical trial NCT02552147 · COMPLETED
Trial details
- NCT number
- NCT02552147
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-11-17
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.